Evidence map›Paper›PMID 27362433›Full record

ArticlePloS one2016

Establishment of Nephrin Reporter Mice and Use for Chemical Screening.

Junichi Tsuchida, Taiji Matsusaka, Masato Ohtsuka, Hiromi Miura, Yukiko Okuno, Katsuhiko Asanuma, Takahiko Nakagawa, Motoko Yanagita, Kiyoshi Mori

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Pronuclear Injection-Based Targeted Transgenesis.Current protocols in human genetics · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Junichi TsuchidaTMK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Taiji MatsusakaInstitute of Medical Science, Tokai University, Isehara, Kanagawa, Japan.
Masato OhtsukaInstitute of Medical Science, Tokai University, Isehara, Kanagawa, Japan.
Hiromi MiuraInstitute of Medical Science, Tokai University, Isehara, Kanagawa, Japan.
Yukiko OkunoMedical Research Support Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Katsuhiko AsanumaTMK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takahiko NakagawaTMK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Motoko YanagitaTMK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kiyoshi MoriTMK Project, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID http://orcid.org/0000-0002-7285-8351
Kyoto University · JPTokai University · JPUniversity of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrin is a critical component of glomerular filtration barrier, which is important to maintain glomerular structure and avoid proteinuria. Downregulation of nephrin expression is commonly observed at early stage of glomerular disorders, suggesting that methods to increase nephrin expression in podocytes may have therapeutic utility. Here, we generated a knockin mouse line carrying single copy of 5.5 kb nephrin promoter controlling expression of enhanced green fluorescent protein (EGFP) at Rosa26 genomic locus (Nephrin-EGFP mouse). In these mice, EGFP was specifically expressed in podocytes. Next, we isolated and cultivated glomeruli from these mice, and developed a protocol to automatically quantitate EGFP expression in cultured glomeruli. EGFP signal was markedly reduced after 5 days of culture but reduction was inhibited by vitamin D treatment. We confirmed that vitamin D increased mRNA and protein expression of endogenous nephrin in cultivated glomeruli. Thus, we generated a mouse line converting nephrin promoter activity into fluorescence, which can be used to screen compounds having activity to enhance nephrin gene expression.

Indexed as

AnimalsCells, CulturedGreen Fluorescent ProteinsKidney GlomerulusMembrane ProteinsMiceMice, TransgenicPodocytesPromoter Regions, Geneticenhanced green fluorescent proteinGreen Fluorescent ProteinsMembrane Proteinsnephrin

Identifiers

PMID27362433
PMCPMC4928931
OpenAlexW2465703268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.